| Health / Medical Topics |
Dinitrophenyl-Modified Autologous Renal Cell Carcinoma Tumor cell Vaccine
A cancer vaccine consisting of autologous renal cell carcinoma (RCC) tumor cells modified with the hapten 2,4-dinitrophenol (DNP) with potential immunostimulating and antineoplastic activities. Administration of DNP-modified autologous renal cell carcinoma tumor cell vaccine may induce a cytotoxic T-lymphocyte (CTL) response against renal cell carcinoma tumor cells. DNP conjugation may enhance the immunogenicity of weakly immunogenic antigens. (NCI Thesaurus)
YOU MAY ALSO LIKE
Nitroaromatic compounds containing two nitrogen groups on a phenyl ring used as pharmaceuticals, pesticides, explosives, and comprise a group of environmental…
A small molecule containing 2 phenol rings, characterized as a hapten for use in vaccine preparation. Dinitrophenyl by itself will not elicit…
Irritants and reagents for labeling terminal amino acid groups.
A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a…
A substance being studied in the treatment of advanced melanoma (a type of skin cancer) and other types of cancer. It blocks…
A condition in which abnormal cells are found in the lining of a breast duct (milk duct). Having DIN may increase the…
